About Nabsys
Nabsys is a company based in Providence (United States) founded in 2004 by Barrett Bready was acquired by Hitachi High-Tech Corporation in August 2024. Nabsys has raised $144.3 million across 15 funding rounds from investors including HHS, Hitachi High-Tech Corporation and NHGRI. The company has 44 employees as of December 31, 2022. Nabsys offers products and services including OhmX Platform, Electronic Genome Mapping, Sample Prep Kit, Nanodetectors, and Bioinformatics. Nabsys operates in a competitive market with competitors including Cepheid, PacBio, Fluidigm, Complete Genomics and GenapSys, among others.
- Headquarter Providence, United States
- Employees 44 as on 31 Dec, 2022
- Founders Barrett Bready
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nabsys Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$144.3 M (USD)
in 15 rounds
-
Latest Funding Round
$13 M (USD), Series E
Nov 09, 2022
-
Investors
HHS
& 5 more
-
Employee Count
44
as on Dec 31, 2022
-
Acquired by
Hitachi High-Tech Corporation
(Aug 01, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nabsys
Nabsys offers a comprehensive portfolio of products and services, including OhmX Platform, Electronic Genome Mapping, Sample Prep Kit, Nanodetectors, and Bioinformatics.
Enables whole genome structural variant detection with high resolution.
Facilitates analysis of genomic structural variations for research.
Supports preparation for structural variant detection processes.
Delivers high-resolution electronic detection of DNA variations.
Provides analytical software for interpreting genomic data.
People of Nabsys
Unlock access to complete
Funding Insights of Nabsys
Nabsys has successfully raised a total of $144.3M across 15 strategic funding rounds. The most recent funding activity was a Series E round of $13 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nabsys
Nabsys has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Hitachi High-Tech Corporation and NHGRI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Locked | Locked | Locked | |
|
Seed and early-stage investments in US tech sectors are made.
|
Locked | Locked | Locked | |
|
VC investments are directed toward US and UK companies.
|
Locked | Locked | Locked |
Investor details for Nabsys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nabsys
Investment portfolio details for Nabsys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nabsys
Detailed financials for Nabsys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nabsys Comparisons
Peer comparison for Nabsys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nabsys
Nabsys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, PacBio, Fluidigm, Complete Genomics and GenapSys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Instruments for life sciences research and applications are developed.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
Detailed competitors of Nabsys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nabsys
Complete news archive for Nabsys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nabsys
Nabsys was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Nabsys is headquartered in Providence, United States. It is registered at Providence, Rhode Island, United States.
Barrett Bready is the current CEO of Nabsys. They have also founded this company.
Nabsys is a funded company, having raised a total of $144.3M across 15 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Nabsys is 44.
Nabsys was founded in 2004 in Providence, United States, within the biotechnology sector. Solid-state nano detectors are developed by the company for analyzing long DNA molecules at high velocity. Sequence-specific tags are identified on the DNA, with data subsequently validated and characterized through proprietary software tools. Operations center on genome mapping technologies to support sequencing applications.
Nabsys's top competitors include Cepheid, PacBio and Complete Genomics.
Nabsys offers OhmX Platform, Electronic Genome Mapping, Sample Prep Kit, Nanodetectors, and Bioinformatics.
Nabsys has 6 investors. Key investors include HHS, Hitachi High-Tech Corporation, NHGRI, Bay City Capital, and PJC.